Dietary phosphorus, blood pressure and incidence of hypertension in the Atherosclerosis Risk in Communities (ARIC) Study and the Multi-Ethnic Study of Atheosclerosis (MESA)

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN 55454, USA.
Hypertension (Impact Factor: 6.48). 03/2010; 55(3):776-84. DOI: 10.1161/HYPERTENSIONAHA.109.143461
Source: PubMed


Greater phosphorus intake has been associated with lower levels of blood pressure in cross-sectional studies. This association, however, has not been assessed prospectively. We studied 13 444 participants from the Atherosclerosis Risk in Communities cohort and the Multi-Ethnic Study of Atherosclerosis, with diet assessed at baseline using validated food frequency questionnaires. Blood pressure and use of antihypertensive medication were determined at baseline and during follow-up visits. Compared with individuals in the lowest quintile of phosphorus intake at baseline, those in the highest quintile had lower baseline systolic and diastolic blood pressures after adjustment for dietary and nondietary confounders (-2.0 mm Hg [95% CI: -3.6 to -0.5], P for trend=0.01; and -0.6 [95% CI: -1.6 to +0.3], P for trend=0.20, respectively). During an average 6.2 years of follow-up, 3345 cases of hypertension were identified. Phosphorus intake was associated with the risk of hypertension (hazard ratio: 0.80 [95% CI: 0.80 to 1.00], comparing extreme quintiles; P for trend=0.02) after adjustment for nondietary factors but not after additional adjustment for dietary variables (hazard ratio: 1.01 [95% CI: 0.82 to 1.23], P for trend=0.88). Phosphorus from dairy products but not from other sources was associated with lower baseline blood pressure and reduced risk of incident hypertension. Hazard ratios (95% CIs) comparing extreme quintiles were 0.86 (0.76 to 0.97; P for trend=0.01) for phosphorus from dairy foods and 1.04 (0.93 to 1.17; P for trend=0.48) for phosphorus from other foods. These findings could indicate an effect of phosphorus in conjunction with other dairy constituents or of dairy itself without involvement of phosphorus.

Download full-text


Available from: Aurelian Bidulescu
  • Source
    • "There are few examples of similar collaborations, and none have been conducted in an indigenous population. Three collaborations of studies have focused on White populations where data sets were harmonized to compare prevalence of risk factors (16) or to evaluate predictors of endpoints (17,18). Neither of the latter 2 used identical methods for follow-up. "
    [Show abstract] [Hide abstract]
    ABSTRACT: According to health status reports, chronic disease prevalence appears to be rising in western Alaska Native (AN) people, and accurate population-based data are needed. Four cohort studies of western AN people were conducted in the Norton Sound and Yukon-Kuskokwim regions, but none have been large enough to allow reliable estimates of rates of chronic diseases and evaluate their risk factors. In this article, the methods used to combine 4 major cohort studies of rural western AN people are described and the benefits and challenges encountered in combining data and standardizing surveillance methods for these studies are discussed. Tribal permission was obtained for each cohort study and the consolidated study. Data from baseline exams were directly combined or harmonized into new variables. Common surveillance methods were developed and implemented to identify incidence and risk factors for cardiovascular disease (CVD) events and type 2 diabetes. A cohort of 4,569 western AN participants (2,116 men and 2,453 women), aged 18-95 years, was established to study CVD and diabetes prevalence. Prospective surveillance data over an average 6.7-year follow-up can now be used to study CVD and diabetes incidence and associated risk factors in a subset of 2,754 western AN participants (1,218 men and 1,536 women) who consented to initial surveillance. The combined cohort provides statistical power to examine incidence rates and risk factors for CVD and diabetes and allows for analyses by geographic region. The data can be used to develop intervention programmes in these populations and others.
    Full-text · Article · May 2013
  • Source
    • "Dairy foods may reduce the risk for cognitive impairment by modifying vascular factors, including components of the metabolic syndrome, linked to detrimental brain changes particularly via weight loss. Specific components of dairy foods that may be of benefit include calcium (weight and fat reduction, cholesterol reduction) (Teegarden, 2005; van Meijl, Vrolix, & Mensink, 2008; Zemel, 2004, 2005; Zemel et al., 2009), whey protein (weight and fat reduction) (Baer et al., 2011; Luhovyy, Akhavan, & Anderson, 2007; Teegarden, 2005; Zemel, 2004, 2005), vitamin D (glucose homeostasis) (Teegarden & Donkin, 2009; von Hurst, Stonehouse, & Coad, 2010), magnesium (blood pressure regulation , glucose homeostasis, cholesterol reduction) (Ma, Lawson, Liese, Bell, & Mayer-Davis, 2006; Saris, Mervaala, Karppanen, Khawaja, & Lewenstam, 2000; Singh, Rastogi, Sharma, Saharia, & Kulshretha, 1990; Sontia & Touyz, 2007; Weglicki et al., 1996), and phosphorus (blood pressure regulation) (Alonso et al., 2010). The role that dairy constituents may play in impacting upon relationships between metabolic syndrome and cognitive decline has been recently discussed in an excellent review by Camfield et al. (2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: All individuals will experience some degree of cognitive impairment in their later years. Diet is one readily modifiable factor that may influence cognitive function and psychological well-being. Very little research has considered the potential role of dairy foods in modulating cognitive and psychological functions. The objective of this study was to determine the effect of a high intake of reduced fat dairy food on cognitive performance. Overweight adults with habitually low dairy intakes (< two serves/day) were recruited for a 12 month crossover dietary intervention trial and randomised to a high (four serves/day) or low (one serve/day) intake of reduced fat dairy, crossing over to the alternate diet after 6 months. Participants were tested at the end of each 6 month diet period on multiple measures of cognitive performance, including memory, information processing speed, executive function, attention and abstract reasoning. In 38 participants who completed the trial (average age=52±2 years; BMI=31.5±0.8 kg/m(2)), spatial working memory performance was marginally better following 6 months of the high dairy diet compared with the low dairy diet. Increasing the dairy intake of habitually low dairy consumers may have the potential to improve working memory.
    Full-text · Article · Mar 2012 · Appetite
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We summarized existing evidence stemming from laboratory, clinical, and epidemiological studies regarding the differential association between low-fat or whole-fat dairy products and blood pressure control. We identified seven, large, prospective cohorts and one randomized trial that addressed the differential effect of low-fat versus whole-fat dairy products on blood pressure control or on the incidence of hypertension. An inverse association between low-fat dairy consumption and the risk of hypertension was found in most studies, whereas no risk reduction was observed for whole-fat dairy products. Several mechanisms might account for the blood-pressure-lowering effect of dairy products. The observed differential association may be attributable to the detrimental effect of saturated fat. In conclusion, low-fat dairy products but not whole-fat dairy products may contribute to improve blood pressure control and to reduce the incidence of hypertension.
    Full-text · Article · Dec 2012
Show more